欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5583/001
药品名称Gaviscon Double Action Mixed Berries Flavour Oral Suspension
活性成分
    • Calcium carbonate 325.0 mg
    • Sodium alginate 500.0 mg
    • Sodium bicarbonate 213.0 mg
剂型Oral suspension
上市许可持有人Reckitt Benckiser Healthcare B.V. Siriusdreef 14 2132 WT Hoofddorp
参考成员国 - 产品名称Netherlands (NL)
Gaviscon Duo bosvruchtensmaak 500 mg/213 mg/325 mg, suspensie voor oraal gebruik
互认成员国 - 产品名称
    • Denmark (DK)
      Claulieve Mixed Berries
    • Bulgaria (BG)
      Gaviscon Double Action Mixed Berries Flavour Oral Suspension
    • Iceland (IS)
    • Romania (RO)
      Gaviscon DoubleAction cu aromă de zmeură suspensie orală
    • Austria (AT)
    • France (FR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      -
    • Estonia (EE)
    • Hungary (HU)
许可日期2024/04/23
最近更新日期2024/11/28
药物ATC编码
    • A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase